-
1 Comment
Apollo Healthcare Corp is currently in a long term downtrend where the price is trading 31.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.0.
Apollo Healthcare Corp's total revenue rose by 108.6% to $87M since the same quarter in the previous year.
Its net income has increased by 789.9% to $22M since the same quarter in the previous year.
Finally, its free cash flow grew by 710.3% to $40M since the same quarter in the previous year.
Based on the above factors, Apollo Healthcare Corp gets an overall score of 4/5.
| Sector | Consumer Defensive |
|---|---|
| Industry | Household & Personal Products |
| Exchange | TO |
| CurrencyCode | CAD |
| ISIN | CA0376311084 |
| Market Cap | 327M |
|---|---|
| Beta | 1.52 |
| PE Ratio | 7.91 |
| Target Price | None |
| Dividend Yield | None |
Apollo Healthcare Corp. is a private equity firm specializing in buyouts. It prefer to invest in founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented businesses. The firm prefers to invest in private label consumer staples and aviation finance and asset management companies. It prefer to have majority stake in companies. Acasta Enterprises Inc. was founded in 2015 and is based in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AHC.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
